TY - JOUR
T1 - Future perspectives
T2 - What lies ahead for Neuronal Ceroid Lipofuscinosis research?
AU - Cooper, Jonathan D.
AU - Mole, Sara E.
N1 - Publisher Copyright:
© 2020
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Progress is being made in all aspects of Neuronal Ceroid Lipofuscinosis (NCL) research, resulting in many recent advances. These advances encompass several areas that were previously thought intractable, ranging from basic science, through to a better understanding of the clinical presentation of different forms of NCL, therapeutic development, and new clinical trials that are underway. Increasing numbers of original NCL research papers continue to be published, and this new sense of momentum is greatly encouraging for the field. Here, we make some predictions as to what we can anticipate in the next few years.
AB - Progress is being made in all aspects of Neuronal Ceroid Lipofuscinosis (NCL) research, resulting in many recent advances. These advances encompass several areas that were previously thought intractable, ranging from basic science, through to a better understanding of the clinical presentation of different forms of NCL, therapeutic development, and new clinical trials that are underway. Increasing numbers of original NCL research papers continue to be published, and this new sense of momentum is greatly encouraging for the field. Here, we make some predictions as to what we can anticipate in the next few years.
KW - Batten disease
KW - Future perspectives
KW - International congress
KW - Neuronal Ceroid Lipofuscinoses
UR - http://www.scopus.com/inward/record.url?scp=85078162178&partnerID=8YFLogxK
U2 - 10.1016/j.bbadis.2020.165681
DO - 10.1016/j.bbadis.2020.165681
M3 - Review article
C2 - 31926264
AN - SCOPUS:85078162178
SN - 0925-4439
VL - 1866
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 9
M1 - 165681
ER -